SCHEMBL4697948

SCHEMBL4697948

CC(C)(C)OC(=O)NC1CCN(C(=O)c2ccc([N+](=O)[O-])cc2Cl)CC1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.51
MAPT P10636 3/20 0.45
TP53 P04637 1/20 0.45
NAMPT P43490 1/20 0.45
PARP1 P09874 2/20 0.44
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 3/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
MCL1 Q07820 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13419583 0.85 ALDH1A1 (0.58) DRD2MAPTLMNASMN1; SMN2ALDH1A1
SCHEMBL29268404 0.84 NPC1 (0.49) DRD2NAMPTPARP1LMNATDP1
SCHEMBL4700826 0.84 PARP1 (0.50) DRD2NAMPTPARP1TDP1MCL1
SCHEMBL3510744 0.84 ALDH1A1 (0.50) MAPTTP53LMNASMN1; SMN2CTDSP1
SCHEMBL29067082 0.83 EPHX2 (0.59) DRD2NAMPTLMNAALDH1A1POLB
SCHEMBL22405617 0.82 ALDH1A1 (0.60) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL22405450 0.81 MAPT (0.47) MAPTTP53LMNASMN1; SMN2NPC1
SCHEMBL22405571 0.80 LMNA (0.51) MAPTTP53LMNASMN1; SMN2TDP1
SCHEMBL34473423 0.80 LMNA (0.51) MAPTTP53LMNASMN1; SMN2TDP1
SCHEMBL34472552 0.80 ALDH1A1 (0.58) MAPTTP53LMNASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987037-A2 FUSED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-11-05 EP disclosed
WO-2007097470-A2 FUSED NITROGEN- COMPRISING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-08-30 WO disclosed